Search
for
Sort by
Research 30 of 1000+
- Partial Proteasome Inhibitors Induce Hair Follicle Growth by Stabilizing β-Catenin
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The role of lymphocytes in the development and treatment of alopecia areata
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Cutaneous drug reactions
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Dermatologic Adverse Events from Cancer Treatments
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- The JAK/STAT signaling pathway: from bench to clinic
- Wnt/β‐catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles